Genetics of systemic sclerosis-associated pulmonary arterial hypertension: Recent progress and current concepts

Current Rheumatology Reports

Volumn 11, Issue 2, 2009, Pages 89-96

  Shah, Sanjiv J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CARBON MONOXIDE; ENDOGLIN; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; SEROTONIN TRANSPORTER; SHAKER POTASSIUM CHANNEL;

BIOINFORMATICS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HEREDITY; HUMAN; LINKAGE ANALYSIS; LUNG DIFFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SCREENING TEST; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; GENETICS; HAPLOTYPE; HUMAN GENOME; PATHOLOGY; PULMONARY ARTERY;

DATABASES, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HUMANS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC;

EID: 65549132025     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0013-5     Document Type: Review

References (51)

1. L.J. Rubin D.B. Badesch 2005 Evaluation and management of the patient with pulmonary arterial hypertension Ann Intern Med 143 282 292 16103472
2. L.J. Rubin 2004 Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 7S 10S 15249491 10.1378/chest.126.1-suppl.7S (Pubitemid 38932338)
3. Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23-25, 2003
4. J Am Coll Cardiol 2004, 43:1S-90S.
5. A. Ramirez J. Varga 2004 Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management Treat Respir Med 3 339 352 15658881 10.2165/00151829-200403060-00002
6. J. Varga 2002 Pulmonary hypertension in systemic sclerosis: bete noire no more? Curr Opin Rheumatol 14 666 670 12410089 10.1097/00002281-200211000-00007 (Pubitemid 35191554)
7. A.J. MacGregor R. Canavan C. Knight, et al. 2001 Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival Rheumatology (Oxford) 40 453 459 10.1093/rheumatology/40.4.453 1:STN:280:DC%2BD3M3it1KktA%3D%3D
8. S.M. Kawut D.B. Taichman C.L. Archer-Chicko, et al. 2003 Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis Chest 123 344 350 12576350 10.1378/chest.123.2.344 (Pubitemid 36269414)
9. D. Mukerjee D. St. George B. Coleiro, et al. 2003 Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach Ann Rheum Dis 62 1088 1093 14583573 10.1136/ard.62.11.1088 1:STN:280:DC%2BD3srgslKquw%3D%3D (Pubitemid 37323574)
10. T. Thenappan S.J. Shah S. Rich, et al. 2007 A USA-based registry for pulmonary arterial hypertension: 1982-2006 Eur Respir J 30 1103 1110 17804449 10.1183/09031936.00042107 1:STN:280:DC%2BD2sjhs1aisg%3D%3D (Pubitemid 351194756)
11. J.G. Coghlan C. Handler 2006 Connective tissue associated pulmonary arterial hypertension Lupus 15 138 142 16634366 10.1191/0961203306lu2280rr 1:STN:280:DC%2BD283is1Omug%3D%3D
12. E. Hachulla J.G. Coghlan 2004 A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism Ann Rheum Dis 63 1009 1014 15308510 10.1136/ard.2003.017673 1:CAS:528: DC%2BD2cXnvFWksbk%3D (Pubitemid 39120347)
13. T.M. Bull 2007 Screening and therapy of pulmonary hypertension in systemic sclerosis Curr Opin Rheumatol 19 598 603 17917541 10.1097/BOR. 0b013e3282ec67d4 (Pubitemid 47530881)
14. S.M. Proudman W.M. Stevens J. Sahhar D. Celermajer 2007 Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment Intern Med J 37 485 494 17547726 10.1111/j.1445-5994.2007.01370.x 1:STN:280:DC%2BD2szjsFynsA%3D%3D (Pubitemid 46855082)
15. J.H. Newman R.C. Trembath J.A. Morse, et al. 2004 Genetic basis of pulmonary arterial hypertension: current understanding and future directions J Am Coll Cardiol 43 33S 39S 15194176 10.1016/j.jacc.2004.02.028 1:CAS:528:DC%2BD2cXlsFyhtrk%3D (Pubitemid 38759715)
16. J.R. Thomson R.D. Machado M.W. Pauciulo, et al. 2000 Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family J Med Genet 37 741 745 11015450 10.1136/jmg.37.10.741 1:CAS:528:DC%2BD3cXnvVOisrs%3D
17. K.B. Lane R.D. Machado M.W. Pauciulo, et al. 2000 Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium Nat Genet 26 81 84 10973254 10.1038/79226 1:CAS:528:DC%2BD3cXmsVKku7Y%3D (Pubitemid 30692862)
18. Z. Deng J.H. Morse S.L. Slager, et al. 2000 Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am J Hum Genet 67 737 744 10903931 10.1086/303059 1:CAS:528:DC%2BD3cXms1Wgtro%3D (Pubitemid 30659603)
19. R.C. Trembath J.R. Thomson R.D. Machado, et al. 2001 Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia N Engl J Med 345 325 334 11484689 10.1056/NEJM200108023450503 1:CAS:528:DC%2BD3MXmtVGqs7Y%3D (Pubitemid 32703235)
20. M.D. Mayes M. Trojanowska 2007 Genetic factors in systemic sclerosis Arthritis Res Ther 9 Suppl2 S5 17767743 10.1186/ar2189
21. L. Appelbaum M. Yigla D. Bendayan, et al. 2001 Primary pulmonary hypertension in Israel: a national survey Chest 119 1801 1806 11399707 10.1378/chest.119.6.1801 1:STN:280:DC%2BD3MzjtFKjsg%3D%3D (Pubitemid 32744938)
22. S. Eddahibi A. Chaouat N. Morrell, et al. 2003 Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease Circulation 108 1839 1844 14530202 10.1161/01.CIR.0000091409. 53101.E8 1:CAS:528:DC%2BD3sXnvVajur4%3D (Pubitemid 37296093)
23. C. Fonseca G.E. Lindahl M. Ponticos, et al. 2007 A polymorphism in the CTGF promoter region associated with systemic sclerosis N Engl J Med 357 1210 1220 17881752 10.1056/NEJMoa067655 1:CAS:528:DC%2BD2sXhtVOhtb7J (Pubitemid 47443180)
24. M.B. Tew F.C. Arnett J.D. Reveille F.K. Tan 2002 Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases Arthritis Rheum 46 2829 2830 12384956 10.1002/art.10487 (Pubitemid 36118956)
25. J. Morse R. Barst E. Horn, et al. 2002 Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations J Rheumatol 29 2379 2381 12415595
26. S. Mattuzzi S. Barbi A. Carletto, et al. 2007 Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis J Rheumatol 34 997 1004 17444587 1:CAS:528: DC%2BD2sXmtV2rtLo%3D
27. J. Wipff A. Kahan E. Hachulla, et al. 2007 Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension Rheumatology (Oxford) 46 622 625 10.1093/rheumatology/kel378 1:CAS:528:DC%2BD2sXjslOnt7w%3D (Pubitemid 46523307)
28. S.J. Chanock T. Manolio M. Boehnke, et al. 2007 Replicating genotype-phenotype associations Nature 447 655 660 17554299 10.1038/447655a 1:CAS:528:DC%2BD2sXmtFemur4%3D (Pubitemid 46889722)
29. T.M. Bull C.D. Coldren M.W. Geraci N.F. Voelkel 2007 Gene expression profiling in pulmonary hypertension Proc Am Thorac Soc 4 117 120 17202300 10.1513/pats.200605-128JG 1:CAS:528:DC%2BD2sXhsF2ktL4%3D (Pubitemid 46067570)
30. T.M. Bull C.D. Coldren M. Moore, et al. 2004 Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension Am J Respir Crit Care Med 170 911 919 15215156 10.1164/rccm.200312-1686OC (Pubitemid 39359232)
31. D.N. Grigoryev S.C. Mathai M.R. Fisher, et al. 2008 Identification of candidate genes in scleroderma-related pulmonary arterial hypertension Transl Res 151 197 207 18355767 10.1016/j.trsl.2007.12.010 1:CAS:528: DC%2BD1cXjs1Sqt7s%3D
32. R.C. Starling M. Pham H. Valantine, et al. 2006 Molecular testing in the management of cardiac transplant recipients: initial clinical experience J Heart Lung Transplant 25 1389 1395 17178330 10.1016/j.healun.2006.10.002 (Pubitemid 44909474)
33. K.V. Ballman 2008 Genetics and genomics: gene expression microarrays Circulation 118 1593 1597 18838575 10.1161/CIRCULATIONAHA.107.714600
34. K. Musunuru S. Kathiresan 2008 HapMap and mapping genes for cardiovascular disease Circ Cardiovasc Genet 1 66 71 10.1161/CIRCGENETICS.108. 813675 1:CAS:528:DC%2BD1cXhsVGgt7zI
35. K.A. Frazer D.G. Ballinger D.R. Cox, et al. 2007 A second generation human haplotype map of over 3.1 million SNPs Nature 449 851 861 17943122 10.1038/nature06258 1:CAS:528:DC%2BD2sXhtFOjt7jL (Pubitemid 47598626)
36. E. Zeggini W. Rayner A.P. Morris, et al. 2005 An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets Nat Genet 37 1320 1322 16258542 10.1038/ng1670 1:CAS:528: DC%2BD2MXht1Ggsr7I (Pubitemid 41722186)
37. Barnes M: Bioinformatics for Geneticists: A Bioinformatics Primer for the Analysis of Genetic Data. New York: John Wiley & Sons; 2007.
38. M.R. Zamora R.F. O'Brien R.B. Rutherford J.V. Weil 1990 Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon Lancet 336 1144 1147 1978025 10.1016/0140-6736(90)92766-B 1:STN:280: By6D2c7islY%3D (Pubitemid 20362904)
39. H. Julkunen O. Saijonmaa C. Gronhagen-Riska, et al. 1991 Raised plasma concentrations of endothelin-1 in systemic lupus erythematosus Ann Rheum Dis 50 526 527 1877866 10.1136/ard.50.7.526-c 1:STN:280:By6A2crkt1Q%3D
40. M. Humbert G. Simonneau 2005 Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases Nat Clin Pract Rheumatol 1 93 101 16932638 10.1038/ncprheum0048 1:CAS:528:DC%2BD28Xis1yisrw%3D
41. D.J. Stewart R.D. Levy P. Cernacek D. Langleben 1991 Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114 464 469 1994793 1:STN:280:By6C3sngsFY%3D
42. M. Nootens E. Kaufmann T. Rector, et al. 1995 Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels J Am Coll Cardiol 26 1581 1585 7594089 10.1016/0735-1097(95)00399-1 1:CAS:528:DyaK28XlvFCquw%3D%3D
43. D. Langleben 2007 Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension Clin Chest Med 28 117 125 17338931 10.1016/j.ccm.2006.11.002 (Pubitemid 46330544)
44. D. Abraham O. Distler 2007 How does endothelial cell injury start? The role of endothelin in systemic sclerosis Arthritis Res Ther 9 Suppl2 S2 17767740 10.1186/ar2186
45. C. Fonseca E. Renzoni P. Sestini, et al. 2006 Endothelin axis polymorphisms in patients with scleroderma Arthritis Rheum 54 3034 3042 16947775 10.1002/art.22036 1:CAS:528:DC%2BD28XhtFWksLbJ (Pubitemid 44497785)
46. C.V. Remillard D.D. Tigno O. Platoshyn, et al. 2007 Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension Am J Physiol Cell Physiol 292 C1837 1853 17267549 10.1152/ajpcell.00405.2006 1:CAS:528:DC%2BD2sXls1yju74%3D (Pubitemid 47080568)
47. Y. Kawaguchi A. Tochimoto M. Hara, et al. 2006 NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity Arthritis Res Ther 8 R104 16813666 10.1186/ar1894 (Pubitemid 43264488)
48. A. Crilly J. Hamilton C.J. Clark, et al. 2002 Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis Ann Rheum Dis 61 678 681 12117671 10.1136/ard.61.8.678 1:CAS:528: DC%2BD38XmsVajtbY%3D (Pubitemid 34787703)
49. J.C. Barrett B. Fry J. Maller M.J. Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
50. J. Wang K. Prakasa C. Bomma, et al. 2007 Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance J Am Soc Echocardiogr 20 1058 1064 17555927 10.1016/j.echo.2007.01.038 (Pubitemid 47321066)
51. P.R. Forfia M.R. Fisher S.C. Mathai, et al. 2006 Tricuspid annular displacement predicts survival in pulmonary hypertension Am J Respir Crit Care Med 174 1034 1041 16888289 10.1164/rccm.200604-547OC (Pubitemid 44684453)